Collegium Pharmaceutical: 3Q Earnings Snapshot

Associated Press |

CANTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Thursday reported a loss of $16.5 million in its third quarter.

The Canton, Massachusetts-based company said it had a loss of 50 cents per share. Losses, adjusted for non-recurring costs and stock option expense, came to 25 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 11 cents per share.

The specialty pharmaceutical company posted revenue of $70.2 million in the period, which also fell short of Street forecasts. Five analysts surveyed by Zacks expected $75.4 million.

Collegium Pharmaceutical shares have declined 16 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $15.56, a climb of 55 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Permanent Techs Inc

Permanent Technologies Inc engages in the design and manufacture of multi-faceted, vibration-proof, self-locking nut and bolt systems for use in the fastener industry in the United States. The Company also…